International Journal of Surgery 2026

8 papers
The 2026 edition of the International Journal of Surgery featured research focused on oncological outcomes, surgical complications, and the application of computational biology in clinical settings. Studies addressed treatment strategies for various malignancies, including neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and conversion therapy for locally advanced prostate cancer. Research also examined pancreatic ductal adenocarcinoma through population-based survival analyses and metabolism-based subtyping using machine learning algorithms. Beyond oncology, the journal included investigations into pediatric neuroblastoma complications and the molecular mechanisms of intervertebral disc degeneration. Methodological trends involved the integration of multi-omics, network pharmacology, and molecular dynamics simulations to study conditions like primary ovarian insufficiency. Additionally, the year's publications evaluated machine learning models for predicting surgical site infections following orthopedic procedures. Prolific contributors for the year included researchers such as Baoxin Shen, Chao Song, Daqian Zhou, and Fei Liu. The collected work reflects a shift toward integrating data-driven modeling and molecular analysis with traditional surgical cohort studies.

Top Research Directions

The 5 research directions with International Journal of Surgery 2026 papers, ranked by paper count, next to 2025. Share is the fraction of the edition’s papers in the direction.

#Direction20262025Share 2026Share 20252025 rank
1Computational Target Prediction via Network Pharmacology1012.5%0.0%—
2Interpreting Gene Expression via Functional Enrichment Analysis1012.5%0.0%—
3Modeling Molecular Dynamics Beyond Static Structural Snapshots1012.5%0.0%—
4Overcoming Bioavailability Barriers for Poorly Soluble Compounds1012.5%0.0%—
5Predicting Ligand Protein Binding via Molecular Docking1012.5%0.0%—

Download all directions as CSV

Institutions

Institutions credited by International Journal of Surgery 2026 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.

#InstitutionPapersShare20252025 rank
103dveyr97 1100.0%0—
2Chinese University of Hong Kong 1100.0%0—
3Guangzhou University 1100.0%0—

Download all institutions as CSV

About this data

Papers. International Journal of Surgery 2026 lists 8 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2025 use shares, since the edition went from 71 to 8 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 8 papers (12.5%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Surgery 2026”, https://lacuna.tiptreesystems.com/venue/international-journal-of-surgery/2026.

Papers

Title
A prospective cohort study using the INSRF to identify risk factors for postoperative complications in pediatric neuroblastoma: a single-center analysis
Comment on “Construct validation of machine learning models for predicting surgical site infection risk following ankle fracture surgery”
Integrating multiple omics analyses to elucidate the macrophage-driven “immune cellular senescence fibrosis” axis mechanism in intervertebral disc degeneration
Metabolism pathway-based subtyping in pancreatic adenocarcinoma: an integrated study by bulk RNA-sequence and machine learning algorithms
Multi-target modulation of the homologous recombination pathway by resveratrol promotes DNA damage repair in POI: integrated network pharmacology, molecular dynamics simulation, and experimental valid
Neoadjuvant immunochemotherapy with or without radiotherapy for locally advanced esophageal squamous cell carcinoma: a pooled analysis of two prospective single-arm clinical trials
Preoperative ADT combined with docetaxel for conversion therapy in large-volume and unresectable locally advanced or oligometastatic prostate cancer: a multicenter retrospective study (YHCG-001 study)
Treatment patterns and survival outcomes in pancreatic ductal adenocarcinoma: a large-scale population-based retrospective cohort study